The Wnt-independent role of TCF7l2 in CNS myelin formation and repair
TCF7l2 在中枢神经系统髓磷脂形成和修复中的 Wnt 独立作用
基本信息
- 批准号:9750846
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-01 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAnimal ModelAxonBMP4BiologyBone Morphogenetic ProteinsCell LineageCellsChronicColorectal CancerCre-LoxPDataDefectDemyelinating DiseasesDemyelinationsDevelopmentDiseaseEngineeringEventFailureFamilyFutureGene ExpressionGene TransferGenesGeneticGenetic ModelsGenetic TranscriptionGoalsHistologicHumanIn VitroKnowledgeLaboratoriesLentivirus VectorLesionLinkLipidsMediatingMolecularMolecular TargetMultiple SclerosisMultiple Sclerosis LesionsMyelinMyelin SheathNeonatalNeuraxisOligodendrogliaPathologicPathway interactionsPatientsPeriventricular LeukomalaciaPlayPublic HealthRegenerative MedicineRegulationReportingResearchRoleSignal PathwaySignal TransductionSignaling ProteinStem cellsSystemTCF7L2 geneTestingTherapeuticTimeTransduction GeneWNT Signaling Pathwayautocrinebasebeta catenincancer celldysmyelinationexperimental studygenetic approachin vivoinnovationinsightmembermultimodalitymultiple sclerosis patientmyelinationnervous system disordernoveloligodendrocyte progenitorpostnatalregenerative therapyremyelinationrepairedtherapeutic developmenttranscription factortranslational impact
项目摘要
Oligodendrocytes (OLs) are myelin-forming cells in the central nervous system (CNS). CNS myelin
formation/repair consists of two closely-related sequential events: OL differentiation from oligodendrocyte
progenitor cells and axonal (re)myelination by already differentiated OLs. Defects of these two events result in
abnormalities of CNS myelin formation such as in periventricular leukomalacia and inability of myelin repair
such as in multiple sclerosis. Our long term goal is to study the underlying mechanisms regulating CNS myelin
formation/repair. The expression of the Wnt effector transcription factor 7-like 2 (TCF7l2, a.k.a. TCF4) in
multiple sclerosis lesions is one such promising mechanism.
A well-studied role of TCF7l2 is transcriptionally mediating Wnt/β-catenin signaling in Wnt activated
cells such as colorectal cancer cells. Previous studies from others and our own laboratory have shown that
genetic activation of canonical Wnt/β-catenin signaling pathway inhibits OL differentiation (review Guo et al.,
2015).Therefore, it has been proposed that TCF7l2 inhibits OL differentiation acting through Wnt/β-catenin
signaling. However, we recently reported that conditionally disrupting TCF7l2 by Cre-loxP genetic approach
inhibits neonatal and early postnatal OL differentiation without perturbing Wnt/β-catenin signaling pathway
(Hammond et al., 2015). Based on our genetic data, we propose an alternative hypothesis that TCF7l2, acting
through non-Wnt pathways (Aim 2), is a multimodal positive regulator of CNS myelin formation (Aim 1) that
can be manipulated to promote CNS myelin repair after myelin damage (Aim 3).
In Aim 1, we will specifically ablate TCF7l2 in already differentiated OLs to determine its role in
subsequent axonal myelination and myelin lipid synthesis. The experiments in this Aim will reveal a previously
unrecognized novel role of TCF7l2 in CNS myelination independent of upstream OL differentiation. In Aim 2,
we will use in vivo and in vitro genetic approaches to test the hypothesis that TCF7l2's function as a gene
repressor plays an essential role in CNS myelin formation. This project will unveil a novel link between TCF7l2
and an oligodendroglial autocrine pathway that inhibits OL differentiation and myelination. Our paradigm-
shifting data make it necessary and important to revisit and reevaluate the therapeutic potential of TCF7l2
during CNS myelin repair which has been proposed as an inhibitory factor in human multiple sclerosis. In Aim
3, we will use lentiviral vector-mediated gene transfer to test the alternative hypothesis that enforced TCF7l2
expression promotes OL differentiation and CNS myelination in demyelination animal models. The expected
overall impact of this innovative proposal is that it will fundamentally advance our mechanistic understanding
of CNS myelin formation and of novel role of TCF7l2, and will change our conventional view of inhibiting
TCF7l2 to enhance CNS myelin repair.
少突胶质细胞(OLs)是中枢神经系统(CNS)中的髓磷脂形成细胞。中枢神经系统髓鞘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fuzheng Guo其他文献
Fuzheng Guo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fuzheng Guo', 18)}}的其他基金
The curious case of PARP1 in CNS myelin formation and repair
PARP1 在中枢神经系统髓磷脂形成和修复中的奇特案例
- 批准号:
10445766 - 财政年份:2022
- 资助金额:
-- - 项目类别:
The curious case of PARP1 in CNS myelin formation and repair
PARP1 在中枢神经系统髓磷脂形成和修复中的奇特案例
- 批准号:
10621372 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Using genetic approaches to explore the role of group I PAKs in developmental myelination of the mammalian CNS
使用遗传方法探索 I 组 PAK 在哺乳动物 CNS 发育髓鞘形成中的作用
- 批准号:
10528035 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Glial HIFa: mechanisms and implications in hypoxia/ischemia-induced oligodendroglial pathology
神经胶质HIFa:缺氧/缺血诱导的少突胶质细胞病理学的机制和意义
- 批准号:
10280166 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Glial HIFa: mechanisms and implications in hypoxia/ischemia-induced oligodendroglial pathology
神经胶质HIFa:缺氧/缺血诱导的少突胶质细胞病理学的机制和意义
- 批准号:
10400140 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Glial HIFa: mechanisms and implications in hypoxia/ischemia-induced oligodendroglial pathology
神经胶质HIFa:缺氧/缺血诱导的少突胶质细胞病理学的机制和意义
- 批准号:
10581693 - 财政年份:2021
- 资助金额:
-- - 项目类别:
The Wnt-independent role of TCF7l2 in CNS myelin formation and repair
TCF7l2 在中枢神经系统髓磷脂形成和修复中的 Wnt 独立作用
- 批准号:
9981843 - 财政年份:2016
- 资助金额:
-- - 项目类别:
相似海外基金
Quantification of Neurovasculature Changes in a Post-Hemorrhagic Stroke Animal-Model
出血性中风后动物模型中神经血管变化的量化
- 批准号:
495434 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Bioactive Injectable Cell Scaffold for Meniscus Injury Repair in a Large Animal Model
用于大型动物模型半月板损伤修复的生物活性可注射细胞支架
- 批准号:
10586596 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Comparison of Treatment Strategies for Recovery of Swallow and Swallow-Respiratory Coupling Following a Prolonged Liquid Diet in a Young Animal Model
幼年动物模型中长期流质饮食后吞咽恢复和吞咽呼吸耦合治疗策略的比较
- 批准号:
10590479 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Small animal model for evaluating the impacts of cleft lip repairing scar on craniofacial growth and development
评价唇裂修复疤痕对颅面生长发育影响的小动物模型
- 批准号:
10642519 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Diurnal grass rats as a novel animal model of seasonal affective disorder
昼夜草鼠作为季节性情感障碍的新型动物模型
- 批准号:
23K06011 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Longitudinal Ocular Changes in Naturally Occurring Glaucoma Animal Model
自然发生的青光眼动物模型的纵向眼部变化
- 批准号:
10682117 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A whole animal model for investigation of ingested nanoplastic mixtures and effects on genomic integrity and health
用于研究摄入的纳米塑料混合物及其对基因组完整性和健康影响的整体动物模型
- 批准号:
10708517 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A Novel Large Animal Model for Studying the Developmental Potential and Function of LGR5 Stem Cells in Vivo and in Vitro
用于研究 LGR5 干细胞体内外发育潜力和功能的新型大型动物模型
- 批准号:
10575566 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Elucidating the pathogenesis of a novel animal model mimicking chronic entrapment neuropathy
阐明模拟慢性卡压性神经病的新型动物模型的发病机制
- 批准号:
23K15696 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
The effect of anti-oxidant on swallowing function in an animal model of dysphagia
抗氧化剂对吞咽困难动物模型吞咽功能的影响
- 批准号:
23K15867 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists